BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 18349136)

  • 21. Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway.
    Everaert BR; Van Craenenbroeck EM; Hoymans VY; Haine SE; Van Nassauw L; Conraads VM; Timmermans JP; Vrints CJ
    Int J Cardiol; 2010 Oct; 144(3):350-66. PubMed ID: 20444511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies.
    Marsboom G; Janssens S
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):687-701. PubMed ID: 18510485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cells and transplant arteriosclerosis.
    Xu Q
    Circ Res; 2008 May; 102(9):1011-24. PubMed ID: 18467640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endothelial progenitor cells and atherosclerosis].
    Hamed S; Roguin A
    Harefuah; 2006 May; 145(5):358-61, 397. PubMed ID: 16805218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial progenitor cells: implications for cardiovascular disease.
    Möbius-Winkler S; Höllriegel R; Schuler G; Adams V
    Cytometry A; 2009 Jan; 75(1):25-37. PubMed ID: 19009636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease.
    Sen S; McDonald SP; Coates PT; Bonder CS
    Clin Sci (Lond); 2011 Apr; 120(7):263-83. PubMed ID: 21143202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation.
    Usami K; Mizuno H; Okada K; Narita Y; Aoki M; Kondo T; Mizuno D; Mase J; Nishiguchi H; Kagami H; Ueda M
    J Biomed Mater Res A; 2009 Sep; 90(3):730-41. PubMed ID: 18570318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy.
    Foubert P; Matrone G; Souttou B; Leré-Déan C; Barateau V; Plouët J; Le Ricousse-Roussanne S; Lévy BI; Silvestre JS; Tobelem G
    Circ Res; 2008 Sep; 103(7):751-60. PubMed ID: 18723447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell therapy in bone repair and regeneration.
    Zaidi N; Nixon AJ
    Ann N Y Acad Sci; 2007 Nov; 1117():62-72. PubMed ID: 18056038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases.
    Hung HS; Shyu WC; Tsai CH; Hsu SH; Lin SZ
    Cell Transplant; 2009; 18(9):1003-12. PubMed ID: 19650968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of bone marrow-derived vascular progenitor cell mobilization and maintenance.
    Dimmeler S
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1088-93. PubMed ID: 20453167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and function of cryopreserved bone marrow-derived endothelial progenitor cells.
    Mieno S; Clements RT; Boodhwani M; Sodha NR; Ramlawi B; Bianchi C; Sellke FW
    Ann Thorac Surg; 2008 Apr; 85(4):1361-6. PubMed ID: 18355528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial progenitor cells: a promising therapeutic alternative for cardiovascular disease.
    Dong C; Goldschmidt-Clermont PJ
    J Interv Cardiol; 2007 Apr; 20(2):93-9. PubMed ID: 17391216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial progenitor cells and cardiovascular cell-based therapies.
    Mund JA; Ingram DA; Yoder MC; Case J
    Cytotherapy; 2009; 11(2):103-13. PubMed ID: 19241233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease.
    Dome B; Dobos J; Tovari J; Paku S; Kovacs G; Ostoros G; Timar J
    Cytometry A; 2008 Mar; 73(3):186-93. PubMed ID: 18000872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential implications of vascular wall resident endothelial progenitor cells.
    Ergün S; Tilki D; Hohn HP; Gehling U; Kilic N
    Thromb Haemost; 2007 Nov; 98(5):930-9. PubMed ID: 18000595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial progenitor cells in cell-based therapy for cardiovascular disease.
    Rodriguez-Losada N; Garcia-Pinilla JM; Jimenez-Navarro MF; Gonzalez FJ
    Cell Mol Biol (Noisy-le-grand); 2008 Oct; 54(1):11-23. PubMed ID: 18954547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases.
    Brixius K; Funcke F; Graf C; Bloch W
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):705-10. PubMed ID: 17001208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endothelial progenitor cells (EPCs)--new tools for diagnosis and therapy].
    Ben-Shoshan J; Keren G; George J
    Harefuah; 2006 May; 145(5):362-6, 397. PubMed ID: 16805219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration.
    Rafii S; Lyden D
    Nat Med; 2003 Jun; 9(6):702-12. PubMed ID: 12778169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.